Equities

Bio-Gene Technology Ltd

BGT:ASX

Bio-Gene Technology Ltd

Actions
Basic MaterialsChemicals
  • Price (AUD)0.04
  • Today's Change-0.006 / -13.04%
  • Shares traded175.71k
  • 1 Year change-37.50%
  • Beta0.8036
Data delayed at least 20 minutes, as of Nov 15 2024 03:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Bio-Gene Technology Ltd grew revenues 4.19% from 681.04k to 709.55k while net income improved from a loss of 3.10m to a smaller loss of 2.41m.
Gross margin--
Net profit margin-339.54%
Operating margin-339.60%
Return on assets-68.88%
Return on equity-80.14%
Return on investment-79.31%
More ▼

Cash flow in AUDView more

In 2024, cash reserves at Bio-Gene Technology Ltd fell by 780.97k. Cash Flow from Financing totalled 1.98m or 278.90% of revenues. In addition the company used 2.75m for operations while cash used for investing totalled 5.70k.
Cash flow per share-0.0128
Price/Cash flow per share--
Book value per share0.0139
Tangible book value per share0.0129
More ▼

Balance sheet in AUDView more

Bio-Gene Technology Ltd has little financial risk as the capital structure does not rely on leverage.
Current ratio8.49
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.